These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20204305)
1. The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines. Parra E; Ferreira J Oncol Rep; 2010 Apr; 23(4):1159-65. PubMed ID: 20204305 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11. Mishra MN; Vangara KK; Palakurthi S Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3. Parra E; Ortega A; Saenz L Oncol Rep; 2009 Dec; 22(6):1513-8. PubMed ID: 19885607 [TBL] [Abstract][Full Text] [Related]
4. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study. Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. Menendez JA; Vellon L; Colomer R; Lupu R Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. Liu W; Zhang R Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell line growth. Parra E; Ferreira J Oncol Rep; 2010 Nov; 24(5):1339-45. PubMed ID: 20878129 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB. Parra E; Ferreira J; Saenz L Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958 [TBL] [Abstract][Full Text] [Related]
9. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer. Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel. Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083 [TBL] [Abstract][Full Text] [Related]
11. Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU. Samson AAS; Park S; Kim SY; Min DH; Jeon NL; Song JM J Liposome Res; 2019 Mar; 29(1):44-52. PubMed ID: 29262741 [TBL] [Abstract][Full Text] [Related]
12. Reduced camptothecin sensitivity of estrogen receptor-positive human breast cancer cells following exposure to di(2-ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes. Chou CK; Huang HW; Yang CF; Dahms HU; Liang SS; Wang TN; Kuo PL; Hsi E; Tsai EM; Chiu CC Environ Toxicol; 2019 Apr; 34(4):401-414. PubMed ID: 30720231 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856 [TBL] [Abstract][Full Text] [Related]
14. Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit. Guo J; Verma UN; Gaynor RB; Frenkel EP; Becerra CR Clin Cancer Res; 2004 May; 10(10):3333-41. PubMed ID: 15161687 [TBL] [Abstract][Full Text] [Related]
15. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells. Promkan M; Liu G; Patmasiriwat P; Chakrabarty S Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867 [TBL] [Abstract][Full Text] [Related]
17. [siRNA-cyclin D1 inhibit cell proliferation in breast cancer MCF-7 cell line]. Jiang L; Chen RS; Li JC Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):118-22. PubMed ID: 16944582 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor. Parra E; Gutiérrez L; Ferreira J Oncol Rep; 2013 Aug; 30(2):911-6. PubMed ID: 23715767 [TBL] [Abstract][Full Text] [Related]
19. Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Mei Y; Xie C; Xie W; Tian X; Li M; Wu M Neoplasia; 2007 Oct; 9(10):871-81. PubMed ID: 17971907 [TBL] [Abstract][Full Text] [Related]
20. [Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells: a study in tumor-bearing nude mice]. Wu WD; Fang CH; Yang ZX Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):60-4. PubMed ID: 18227029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]